Appendix 2 of
Song, Mol Vis 2026; 32:354-369.
Appendix 2. Supplementary Figure S2.
To access the data, click or select the words “Appendix 2.” Artemisitene (AT) treatment enhanced mitochondrial function and attenuated ferroptosis in acetazolamide (AZ)–treated SRA01/04 cells. A. Western blot analysis showed the levels of SLC7A11, SLC3A2, and GPX4 in control (Ctrl), AZ-treated, and AZ + AT–treated cells (n = 3). B. Immunofluorescence staining detected SLC7A11 and GPX4 levels in Ctrl, AZ, and AZ + AT–treated cells. Fluorescence intensities were quantified using ImageJ (n = 6). C. MitoSOX, JC-1, and mitochondrial permeability transition pore (mPTP) were labeled by immunofluorescence to assess mitochondrial stress. Fluorescence intensity and JC-1 ratios were analyzed with ImageJ (n = 6). D. Mito-Tracker and Mito-PeDPP staining were used to evaluate mitochondrial integrity. Mito-PeDPP fluorescence was quantified (n = 6). E. Mito-FerroGreen staining assessed mitochondrial ferroptosis levels, with fluorescence intensities analyzed by ImageJ (n = 6). Data were presented as mean ± SD.